WB and IHC analyses demonstrated that the expression levels of Mfn2 and Opa1 were significantly lower in the AKI group than in the control group, whereas pEV treatment significantly upregulated their protein levels (Figure 6I-L). The gene discussed is MFN2; the disease is acute kidney injury.